Highlights
A collection of news and information related to Novartis AG published by this site and its partners.
Displaying items 1-12 of 107
» View wsbtradio.com items only
1
2
3
4
5
6
7
8
9
Next >
-
FDA: Questions of protocol, conflict
The Swampby Andrew Zajac The Obama Administration has made increased transparency a priority, and few government agencies are in greater need of it than the Food and Drug Administration. The FDA's recent handling of conflict of interest allegations against the...Tags: Pharmaceuticals, Newspaper and Magazine, Washington (U.S. state), Health, Heart Attack
-
An insider's view of generic-drug pricing
Bob Toomajian worked for 16 years as Kaiser Permanente's drug purchasing manager for Southern California, giving him an insider's knowledge of how medications are priced before reaching consumers. When it comes to patented name-brand drugs, he told me,...
Tags: Federal Trade Commission, Patents, Copyrights and Trademarks, Target, U.S. Supreme Court, Pharmaceuticals
-
Corporations and execs need penalties that hurt
If you're concerned about corporate crime, 2012 looked like a pretty successful year for the good guys. The Thousand Oaks biotech giant Amgen paid $762 million in fines and penalties and pleaded guilty to a federal charge related to illegal marketing of...
Tags: University of California, Irvine, Phil Angelides , Countrywide Financial Corp., Amgen Inc., Punishment
-
Novartis issues voluntary recall of over the counter pills
Pharmaceutical giant Novartis has issued a massive over the counter pill recall.
The voluntary recall comes after the company got several customer complaints about mislabeled and broken pills.
Certain varieties of Excedrin and Nodoze with December...Tags: Companies and Corporations, Economy, Business and Finance
-
Novartis patent case in India seen as crucial for generic drugs
World NowThe Indian Supreme Court is slated Wednesday to take up a case that aid agencies warn could have sweeping effects on medicine for the global poor, the culmination of a lengthy legal battle between a Swiss drug company and a country known as a mecca for... -
Greek leader pleads for more time to implement reforms
World NowGreek Prime Minister Antonis Samaras launched a high-gear diplomatic offensive aimed at buying his country more time to implement reforms demanded by increasingly impatient European creditors.... -
Report: Paula Deen has diabetes
The Fitness Center - Orlando SentinelUpdate, 5:44 p.m.: A Novartis spokesperson has contacted the Orlando Sentinel to say that the company is not working with Paula Dean. “The rumors that Novartis has signed a multimillion dollar spokesperson deal with Paula Deen for a diabetes... -
We want drama! ABC soap fans rally to keep Erica Kane and her daytime friends on the air
Show TrackerLike sands through the hourglass, daytime soap operas are falling off the TV grid. The recent demise started in 2007 with the cancellation of “Passions” on NBC (and later on DirecTV). Two years later, CBS nixed “The Guiding Light”... -
Pharma cases drive U.S. Attorney's collections
Valley 610The U.S. Attorney’s Office for the Eastern District of Pennsylvania announced Thursday that it has collected nearly $4.4 billion in civil penalties since 2004. While the rules for disbursing those payments between state and federal agencies make it... -
FDA approves swine flu vaccine
Booster ShotsThe Food and Drug Administration this morning approved the pandemic H1N1 influenza vaccine from four different manufacturers, clearing the way for the vaccine to be administered as soon as enough of it is available. The approval was announced to Congress.... -
Swine flu continues slow climb on college campuses
Booster ShotsInfluenza-like illnesses on college campuses, generally assumed to be primarily pandemic H1N1 influenza, grew slightly during the week ending Nov. 6, with 8,951 new cases reported -- an increase of 1% from the previous week. There were 15 hospitalizations... -
Novartis MS drug sent to full FDA for approval
Chicago Breaking BusinessAssociated Press | Federal health experts say a first-of-a-kind multiple sclerosis drug from Novartis is effective at controlling tremors, concentration problems and other symptoms of the debilitating disease. Swiss drugmaker Novartis has asked the Food...
Feb 27, 2010
|Blog| Chicago Tribune
Mar 25, 2013
|Column| Los Angeles Times
Jan 5, 2013
|Column| Los Angeles Times
Jan 9, 2012
|Column| WXIN-LTV
Aug 22, 2012
| Los Angeles Times
Aug 22, 2012
| Los Angeles Times
Jan 13, 2012
| Orlando Sentinel
Apr 21, 2011
| Los Angeles Times
Jan 17, 2011
| Allentown Morning Call
Sep 17, 2009
| Los Angeles Times
Nov 13, 2009
| Los Angeles Times
Jun 10, 2010
| Chicago Tribune
Original site for Novartis AG topic gallery.